APOA1 antibody (C-Term)

Catalog No. ABIN6991518

This anti-APOA1 antibody is a Rabbit Polyclonal antibody detecting APOA1 in WB and ELISA. Suitable for Human and Chicken.

Quick Overview for APOA1 antibody (C-Term) (ABIN6991518)

Target: APOA1 (Apolipoprotein A-I (APOA1))

Reactivity: Human, Chicken

Host: Rabbit

Clonality: Polyclonal

Conjugate: This APOA1 antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Product Details anti-APOA1 Antibody

Binding Specificity: C-Term

Purification: ApoA1 Antibody is affinity chromatography purified via peptide column.

Immunogen: ApoA1 antibody was raised against a 19 amino acid synthetic peptide near the carboxy terminus of human ApoA1. The immunogen is located within the last 50 amino acids of ApoA1.

Isotype: IgG

Application Details

Application Notes: ApoA1 antibody can be used for detection of ApoA1 by Western blot at 1 μ,g/mL.

Antibody validated: Western Blot in chicken samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: ApoA1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,4 °C

Storage Comment: ApoA1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Target Details for APOA1

Target: APOA1 (Apolipoprotein A-I (APOA1))

Alternative Name: ApoA1

Background: ApoA1 Antibody: Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma, which is correlated with cardiovascular disease. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis.

Gene ID: 335

UniProt: P02647

Pathways: Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism